ILKOS: A breakthrough in Biotechnologies

18 April 2017

Installed in Laval, Ilkos Thérapeutique benefits from an investment of 21 M $ to show the effectiveness of its new molecule S42909, which is pointed out for the treatment of the venous ulcer. A challenge of size for this new society of Quebec specialised in biotechnologies.